Skip to main content

ERRATUM article

Front. Microbiol., 09 August 2023
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 14 - 2023 | https://doi.org/10.3389/fmicb.2023.1260368
This article is part of the Research Topic Insights in Antimicrobials, Resistance & Chemotherapy: 2022 View all 17 articles

Erratum: Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

This article is an erratum on:

  1. Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

    1. Read original article
\r\nFrontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

by Meng, S., Xu, Z., Wang, X., Liu, Y., Li, B., Zhang, J., Zhang, X., and Liu, T. (2023). Front. Microbiol. 14:1196072. doi: 10.3389/fmicb.2023.1196072

Due to a production error, the captions did not match the figures correctly.

The artwork of Scheme 1 was missed and replaced by Figure 1, causing all subsequent figures to bear the caption of the next figure.

The publisher apologizes for this mistake. The original article has been updated.

Keywords: photodynamic antimicrobial chemotherapy, photosensitizer, cationic porphyrins, Proteus mirabilis, multi-drug resistant

Citation: Frontiers Production Office (2023) Erratum: Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo. Front. Microbiol. 14:1260368. doi: 10.3389/fmicb.2023.1260368

Received: 17 July 2023; Accepted: 17 July 2023;
Published: 09 August 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2UmI3gwMDA0MDtmcm9udGllcnNpbi5vcmc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.